Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma
- 5 April 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 23 (23) , 4146-4154
- https://doi.org/10.1038/sj.onc.1207490
Abstract
Macrophage migration inhibitory factor (MIF) has been linked to fundamental processes such as control of cell proliferation, cell survival, angiogenesis, and tumor progression. The expression of MIF has been reported in several tumors. However, the precise role of MIF in tumor cells remains unclear. In the present study, we investigated the expression pattern and the function of MIF in neuroblastoma. Our results showed that intracellular MIF was upregulated in neuroblastoma tumor tissues and cell lines. MIF protein expression significantly correlated with the grade of tumor differentiation. In addition, we found that MIF induced a significant close-dependent increase of vascular endothelial growth factor and interleukin-8 secretion. We also observed that an increased MIF expression level correlated with N-Myc protein (the N-myc oncogene product) expression in neuroblastoma tissues. MIF increased the expression of N-myc mRNA and N-Myc protein and induced N-Myc translocation from the cytoplasm to nucleus in neuroblastoma cell lines. MIF-induced N-Myc expression was found to be dependent on ERK signaling pathways. The inhibition of ERK activation reduced MIF-mediated N-Myc expression. These results suggest that MIF may contribute to the progression of neuroblastoma by (a) inducing N-Myc expression and (b) upregulating the expression of angiogenic factors.link_to_subscribed_fulltexKeywords
This publication has 40 references indexed in Scilit:
- Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinomaInternational Journal of Cancer, 2003
- p53 Cellular Localization and Function in NeuroblastomaThe American Journal of Pathology, 2001
- ANGIOGENESIS AND NEUROBLASTOMAS: INTERLEUKIN-8 AND INTERLEUKIN-8 RECEPTOR EXPRESSION IN HUMAN NEUROBLASTOMAJournal of Urology, 2000
- ANGIOGENESIS AND NEUROBLASTOMAS: INTERLEUKIN-8 AND INTERLEUKIN-8 RECEPTOR EXPRESSION IN HUMAN NEUROBLASTOMAJournal of Urology, 2000
- A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor ActivityThe Journal of Experimental Medicine, 1999
- Vascular endothelial growth factor expression in human neuroblastoma: Up-regulation by hypoxiaInternational Journal of Cancer, 1999
- Why does stage 4s neuroblastoma regress spontaneously?The Lancet, 1994
- Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.The Journal of Experimental Medicine, 1994
- Molecular Basis of Clinical Heterogeneity in NeuroblastomaJournal of Pediatric Hematology/Oncology, 1992
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985